Skip to content

Medifast MED Income Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$346.1M-36.3%$385.79M-36.0%$429.7M-36.3%$480.45M-37.6%$543.45M-39.5%
$103.41M-27.1%$110.6M-29.9%$118.43M-33.0%$125.67M-37.4%$141.88M-41.1%
$242.7M-39.6%$275.19M-38.1%$311.27M-37.5%$354.78M-37.7%$401.58M-38.9%
70.1%-3.8pp71.3%-2.5pp72.4%-1.4pp73.8%-0.1pp73.9%+0.7pp
$258.94M-36.5%$289.4M-34.5%$316.97M-34.9%$354.3M-33.8%$407.9M-29.2%
-$16.25M-157%-$14.21M-594%-$5.7M-153%$487K-98.6%-$6.32M-108%
-4.7%-3.5pp-3.7%-4.2pp-1.3%-2.9pp0.1%-4.3pp-1.2%-10.2pp
$8.14M+959%$8.57M+843%$7.72M+425%$5.77M+89.9%-$948K-115%
-$8.11M-11.5%-$5.64M-249%$2.02M-83.6%$6.25M-83.2%-$7.27M-108%
$11.92M+4,433%$13.03M+669%$1.77M-64.5%$2.62M-67.1%-$275K-101%
-$20.02M-186%-$18.67M-993%$248K-96.6%$3.64M-87.6%-$7M-110%
-5.8%-4.5pp-4.8%-5.2pp0.1%-1.0pp0.8%-3.1pp-1.3%-8.8pp
-$1.83-182%-$1.71-1,050%$0.01-98.5%$0.32-88.1%-$0.65-110%
-$1.8M-128%$30K-99.8%$8.26M-65.2%$14.19M-70.0%$6.4M-93.2%
-0.5%-1.7pp0%-2.6pp1.9%-1.6pp3%-3.2pp1.2%-9.3pp
-$16.25M-157%-$14.21M-594%-$5.7M-153%$487K-98.6%-$6.32M-108%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Medifast's revenue?
Medifast (MED) generated $346.1M in revenue over the trailing twelve months, down 36.3% year over year.
Is Medifast profitable?
Medifast is not currently profitable: it reported a net loss of $20.0M over the trailing twelve months, a -5.8% net margin.
What are Medifast's profit margins?
Gross margin is 70.1% and operating margin is -4.7%, with a -5.8% net margin.
What is Medifast's earnings per share?
Medifast's diluted EPS over the trailing twelve months is $-1.83.
Where does Medifast's income statement data come from?
Every line is extracted from Medifast's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.